Research Topics
Genomes and GenesSpecies | STEPHANIE S O'MALLEYSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessationSTEPHANIE S O'MALLEY
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Int J Neuropsychopharmacol 12:589-97. 2009..Given its efficacy and favourable side-effect profile, the 25-mg dose should be considered for future studies of combination therapy...
Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trialSTEPHANIE S O'MALLEY
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
Alcohol Clin Exp Res 31:625-34. 2007..This study investigated the safety and efficacy of naltrexone in combination with Cognitive Behavioral Coping Skills Therapy (CBCST) in a sample of alcohol-dependent women, some with comorbid eating pathology...- A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessationSTEPHANIE S O'MALLEY
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, New Haven 06519, USA
Arch Intern Med 166:667-74. 2006..Thus, this study evaluated whether naltrexone hydrochloride augmentation of nicotine patch therapy improves smoking abstinence and reduces postcessation weight gain more than nicotine patch therapy alone and at what dose... - Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatmentSTEPHANIE S O'MALLEY
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, CT 06519, USA
J Clin Psychopharmacol 27:507-12. 2007..In conclusion, XR-NTX 380 mg prolonged abstinence and reduced the number of heavy drinking days and drinking days in patients who were abstinent for as few as 4 days before treatment initiation... - Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trialSTEPHANIE S O'MALLEY
Yale University School of Medicine, Connecticut Mental Health Center, S202, 34 Park Street, New Haven, CT 06519, USA
Alcohol Clin Exp Res 32:1271-83. 2008..An exploratory aim examined whether the Asn40Asp polymorphism of the mu-opioid receptor gene (OPRM1) predicted response to naltrexone, as had been reported in Caucasians... - Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trialsSTEPHANIE S O'MALLEY
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Arch Intern Med 163:1695-704. 2003..This study tests naltrexone and primary care management (PCM) vs naltrexone and cognitive behavior therapy (CBT) and tests naltrexone maintenance among patients who respond to an initial course of naltrexone combined with PCM vs CBT... - Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE studyRalitza Gueorguieva
Yale University School of Public Health and School of Medicine, New Haven, CT 06520, USA
Drug Alcohol Depend 107:221-9. 2010..It was hypothesized that different treatments may affect different trajectories of drinking... 
Characteristics of older adult problem gamblers calling a gambling helplineMarc N Potenza
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, Room S 104, 34 Park Street, New Haven, CT 06519, USA
J Gambl Stud 22:241-54. 2006..Given data from older adult problem gamblers in treatment, we hypothesized that older as compared with younger adult problem gamblers calling a gambling helpline would be less likely to report gambling-related problems...- Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quitBenjamin A Toll
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA
Nicotine Tob Res 9:597-605. 2007..Information obtained with this questionnaire could be used to counsel patients regarding the importance of medication adherence... - Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE studyRalitza Gueorguieva
Yale University School of Public Health and School of Medicine, New Haven, Connecticut, USA
Alcohol Clin Exp Res 35:523-31. 2011.... - Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokersKelly P Cosgrove
Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
Arch Gen Psychiatry 69:418-27. 2012..Sex differences in availability of nicotinic acetylcholine receptors containing the β(2) subunit (β(2)*-nAChRs) may underlie differential nicotine and tobacco smoking effects and related behaviors in women vs men... - Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorderRobert F Leeman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Nicotine Tob Res 10:1793-809. 2008..Based on these findings, it appears that risk of any smoking and of relapse was associated primarily with heavy drinking days and a hazardous pattern of use respectively, rather than with moderate drinking... - Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratingsBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
Nicotine Tob Res 10:1057-64. 2008.... - Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trialBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
Psychol Addict Behav 21:534-44. 2007..These data suggest that gain-framed messages may be more persuasive than loss-framed messages in promoting early success in smoking cessation for participants who are engaged in treatment... - Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary studyBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
Drug Alcohol Depend 89:302-5. 2007..Moreover, changes in tobacco craving in response to the first cigarette of the day may be a novel predictor of smoking relapse that should be tested in future studies... - A preliminary investigation of varenicline for heavy drinking smokersLisa M Fucito
Department of Psychiatry, CMHC S200, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA
Psychopharmacology (Berl) 215:655-63. 2011..However, varenicline has not been tested in heavy drinkers, and it remains to be determined whether varenicline could reduce alcohol craving and consumption in smokers who are trying to quit smoking... - Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkersErica N Peters
Yale University School of Medicine, Department of Psychiatry, One Long Wharf Drive, Box 18, New Haven, CT 06511, USA
Addict Behav 37:420-6. 2012..98) nonadherence to medication. Findings suggest that young adult heavy drinkers with co-occurring marijuana use exhibit a high-risk clinical profile and may benefit from interventions that increase adherence to medications... - A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gainBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
Addict Behav 33:173-9. 2008.... - Varenicline reduces alcohol self-administration in heavy-drinking smokersSherry A McKee
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
Biol Psychiatry 66:185-90. 2009..Varenicline, a partial nicotinic agonist with high affinity for the alpha4beta2 nAChR receptor, reduced ethanol intake in rodents. We aimed to test whether varenicline would reduce alcohol consumption and alcohol craving in humans... - Message framing for smoking cessation: the interaction of risk perceptions and genderBenjamin A Toll
Department of Psychiatry, Yale University School of Medicine, New Haven CT 06511, USA
Nicotine Tob Res 10:195-200. 2008..These findings suggest that message framing interventions for smoking cessation should consider the influence of gender and risk perceptions associated with quitting on the effectiveness of framed interventions... - A pilot study of naltrexone and BASICS for heavy drinking young adultsRobert F Leeman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
Addict Behav 33:1048-54. 2008..Findings from this small pilot study suggest that naltrexone in combination with BASICS represents a promising strategy to reduce heavy drinking among young adults... - Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administrationSherry A McKee
Department of Psychiatry, Substance Abuse Center CMHC, Yale University School of Medicine, 34 Park St, Suite S 211, New Haven, CT 06519, USA
Psychopharmacology (Berl) 196:189-200. 2008..Nicotine replacement is commonly used to treat tobacco use in heavy-drinking smokers. However, few studies have examined the effect of nicotine replacement on subjective and physiological responses to alcohol and alcohol drinking behavior... - Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patientsHelen M Pettinati
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Alcohol Clin Exp Res 33:350-6. 2009..2005). A 24-week, randomized, double-blind, placebo-controlled study established the efficacy and safety of XR-NTX in this patient population. In this report, the effect of XR-NTX on quality of life (QOL) was examined... - Family history of alcoholism influences naltrexone-induced reduction in alcohol drinkingSuchitra Krishnan-Sarin
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA
Biol Psychiatry 62:694-7. 2007..The purpose of this study was to examine the interactive effects of family history of alcoholism (FH+, FH-) and naltrexone dose (0, 50, 100 mg/day) on alcohol drinking... - Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?Benjamin A Toll
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
Psychol Addict Behav 19:291-5. 2005..Compliance with the TLFB was superior to compliance with the IVR system. This problem should be addressed if researchers wish to use an IVR system in future smoking cessation clinical trials... - Confirmatory factor analysis of the Minnesota Nicotine Withdrawal ScaleBenjamin A Toll
Department of Psychiatry, School of Medicine, Yale University, New Haven, CT 06511, USA
Psychol Addict Behav 21:216-25. 2007..Confirmatory factor analyses of change scores showed that the MNWS symptoms cohere as a syndrome over time. Future investigators should report a total score using all of the items from the MNWS... - Do patients with alcohol dependence respond to placebo? Results from the COMBINE StudyRoger D Weiss
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, and McLean Hospital, Belmont, Massachusetts, USA
J Stud Alcohol Drugs 69:878-84. 2008..The purpose of this study was to examine the nature of the effect of placebo medication plus accompanying medical management in the treatment of alcohol dependence... - Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trialBenjamin A Toll
Yale University School of Medicine, New Haven, CT 06519, USA Yale Cancer Center, New Haven, CT 06519, USA
Drug Alcohol Depend 111:200-6. 2010..Given these encouraging findings, we endeavored to test whether minimization of weight gain might translate to better quit outcomes for a population that is particularly concerned about gaining weight upon quitting... - A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokersAndrea H Weinberger
Program for Research in Smokers with Mental Illness PRISM, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Drug Alcohol Depend 107:188-95. 2010..The primary aim of this study was to determine the safety and efficacy of the monoamine oxidase-B (MAO-B) inhibitor selegiline hydrochloride (SEL, l-Deprenyl; Eldepryl) as an aid for smoking cessation in cigarette smokers... - Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinencePeter Jatlow
Yale University School of Medicine, Department of Laboratory Medicine, New Haven, CT 06520 8035, USA
Drug Alcohol Depend 98:203-9. 2008..These data suggest that while expired CO is a useful and well-established marker in certain contexts, when testing extended abstinence from smoking with non-nicotine medications, cotinine measurements should be preferred... - Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropionCarolyn M Mazure
Women s Health Research at Yale, 135 College Street, Suite 220, New Haven, CT 06510, USA
Drug Alcohol Depend 114:68-72. 2011..This is the first preliminary study examining whether smoking cessation outcomes vary by menstrual cycle phase of quit date in women receiving a 6-week open trial of sustained release (SR) bupropion... - Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humansMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry, West Haven, CT, USA
Pharmacol Biochem Behav 92:135-40. 2009..These findings provide limited support for the potential use of minocycline as a treatment of nicotine dependence... - Correspondence between Interactive Voice Response (IVR) and Timeline Followback (TLFB) reports of drinking behaviorBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, 1 Long Wharf Drive, Box 18, New Haven, CT 06511, and VA Connecticut Healthcare System, USA
Addict Behav 31:726-31. 2006..However, future studies should focus on improving compliance with IVR in this population... - Characteristics of tobacco-smoking problem gamblers calling a gambling helplineMarc N Potenza
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Am J Addict 13:471-93. 2004..The high proportion of callers reporting daily tobacco smoking highlights the need for enhanced smoking cessation efforts in problem gamblers... - Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a reviewRobert F Leeman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Alcohol Alcohol 42:196-206. 2007.... - Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trialJames C Garbutt
Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599 7160, USA
JAMA 293:1617-25. 2005..However, adherence to daily oral pharmacotherapy can be problematic, and clinical acceptance and utility of oral naltrexone have been limited... - Tobacco quitlines need to assess and intervene with callers' hazardous drinkingBenjamin A Toll
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA
Alcohol Clin Exp Res 36:1653-8. 2012.... - Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependenceKelly P Cosgrove
Department of Psychiatry, Yale University School of Medicine and the VACHS, West Haven, CT 06516, USA
Neuropharmacology 60:1318-25. 2011..This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'... - Nicotine and food deprivation decrease the ability to resist smokingRobert F Leeman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Psychopharmacology (Berl) 212:25-32. 2010..Attempts to simultaneously control food intake and smoking may lead to smoking cessation failure. We sought to model this relationship using a human laboratory paradigm of smoking lapse behavior... - Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patchC Neill Epperson
University of Pennsylvania School of Medicine, Department of Psychiatry, Philadelphia, PA 19104 3309, USA
Drug Alcohol Depend 112:1-8. 2010..When used in conjunction with nicotine replacement therapy, naltrexone dose may be important in women... - A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trialsBenjamin A Toll
Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
Addict Behav 33:1606-9. 2008..To estimate abstinence at baseline and during treatment, however, a more comprehensive period of monitoring may be required... - Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatmentLisa M Fucito
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA
Psychol Addict Behav 23:373-9. 2009..These findings provide preliminary support that positive beliefs and attitudes about bupropion are associated with positive attitudes toward quitting, better treatment adherence, and potentially better treatment response... - Smoke and mirrors: magnified beliefs that cigarette smoking suppresses weightMarney A White
Department of Psychiatry, Yale University School of Medicine, United States
Addict Behav 32:2200-10. 2007..These findings indicate that eating and weight-concerned smokers may benefit from psychoeducation concerning the relatively modest and temporary ability of nicotine to suppress weight... - Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking cravingIrina Esterlis
Department of Psychiatry, Yale University and the VACHS, West Haven, CT 06516, USA
Addict Biol 18:370-8. 2013.... - Correction of urine cotinine concentrations for creatinine excretion: is it useful?Peter Jatlow
Department of Laboratory Medicine, Yale University, New Haven, CT 06520, USA
Clin Chem 49:1932-4. 2003 - Modeling the effect of alcohol on smoking lapse behaviorSherry A McKee
Department of Psychiatry, Yale University School of Medicine, Substance Abuse Center CMHC, New Haven, CT 06519, USA
Psychopharmacology (Berl) 189:201-10. 2006..The primary aim of this project was to examine the role of alcohol use in smoking lapse behavior, as alcohol consumption is a known risk factor for poor smoking cessation outcomes... - Parental history of anxiety and alcohol-use disorders and alcohol expectancies as predictors of alcohol-related problemsMeghan E Morean
Department of Psychology, Yale University, 2 Hillhouse Avenue, New Haven, Connecticut 06520, USA
J Stud Alcohol Drugs 70:227-36. 2009..Expectancies of global positive changes and tension reduction were hypothesized to moderate the influence of parental history of alcoholism and anxiety, respectively... - Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veteransDaniel L Dickerson
Yale University, 1 Long Wharf Drive, Box 18, New Haven, CT 06511, USA
Drug Alcohol Depend 99:169-75. 2009..American Indians and Alaska Natives have the highest rates of nicotine dependence in the U.S. However, studies analyzing associations between nicotine dependence and psychiatric and substance use disorders in these groups have been limited... - Internalizing and externalizing dimensions and alcohol use in first time DWI offenders: indirect effects through coping self-efficacyRobert C Schlauch
Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine, USA
Psychol Addict Behav 26:133-9. 2012.... - Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomesErica N Peters
Department of Psychiatry, Yale University School of Medicine, One Long Wharf Drive, New Haven, CT 06511, USA
Psychol Addict Behav 25:312-9. 2011..Future smoking cessation treatment might incorporate strategies related to managing these smokers' sleep habits and physiological dependence on nicotine in order to bolster their cessation outcomes... - Smoking status as a clinical indicator for alcohol misuse in US adultsSherry A McKee
Department of Psychiatry, Substance Abuse Center CMHC, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA
Arch Intern Med 167:716-21. 2007..Our objective was to investigate smoking status as a clinical indicator for alcohol misuse in a national sample of US adults, following clinical care guidelines for the assessment of these behaviors... - Concurrent and predictive validity of drug use and psychiatric diagnosis among first-time DWI offendersRebekka S Palmer
Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine, New Haven, Connecticut 06511, USA
Alcohol Clin Exp Res 31:619-24. 2007..Previous studies have found that driving while intoxicated (DWI) offenders report high rates of substance dependence and other psychiatric disorders... - Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypesRobert F Leeman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Addict Biol 15:109-24. 2010.... - New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trialsRalitza Gueorguieva
Department of Epidemiology, Yale University School of Medicine, New Haven, Connecticut, USA
Biol Psychiatry 61:1290-5. 2007..The objective of this study was to identify distinct trajectories of daily drinking over time in two negative clinical trials and to determine whether naltrexone affected the probability to follow a particular trajectory... - Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingKelly P Cosgrove
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Neuropsychopharmacology 34:2218-26. 2009..Smoking appears to suppress neuroadaptive changes in DA and 5-HT transporters during acute withdrawal from alcohol... - Altered hypothalamic response to food in smokersPaul Y Geha
John B Pierce Laboratory, New Haven, CT 06519, USA
Am J Clin Nutr 97:15-22. 2013..Smoking cessation is often followed by weight gain. Eating behaviors and weight change have been linked to the brain response to food, but it is unknown whether smoking influences this response... - Revisiting the factor structure of the questionnaire on smoking urgesBenjamin A Toll
Department of Psychiatry, Yale University School of Medicine, 1 Long Wharf Drive, Box 18, New Haven, CT 06511, USA
Psychol Assess 16:391-5. 2004..The 2nd model was found to fit the data best. Reliability was also tested using values obtained in this 2nd model, and these estimates were found to be reasonably good. Future research directions for the QSU are discussed... - Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcomeSherry A McKee
Department of Psychiatry, Yale University School of Medicine, Substance Abuse Center CMHC, 34 Park Street, S 211, New Haven, CT 06519, USA
Addict Behav 30:423-35. 2005.... - Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjectsBankole A Johnson
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Stop 7792, San Antonio, TX 78229 3900, USA
J Clin Psychopharmacol 23:281-93. 2003..More side effects were noted with the combination of medications than with either medication alone. Naltrexone administration significantly increased plasma acamprosate levels... - Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?Peter Jatlow
Yale University School of Medicine, New Haven, Connecticut, USA
Alcohol Clin Exp Res 34:968-75. 2010..Additional information needed to develop guidelines for optimal clinical utilization of EtG/EtS measurements is discussed... - The drug effects questionnaire: psychometric support across three drug typesMeghan E Morean
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, Office S 229, 34 Park Street, New Haven, CT, 06519, USA
Psychopharmacology (Berl) 227:177-92. 2013..Thus, the field would benefit from demonstrating the reliability and validity of the DEQ for use across multiple substances... - Current pharmacological treatments for nicotine dependenceTony P George
Center for Nicotine and Tobacco Use Research at Yale, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, Room S 109, SAC, New Haven, CT 06519, USA
Trends Pharmacol Sci 25:42-8. 2004..Several existing medications are being tested as treatments for nicotine dependence and novel investigational agents are under development as effective treatments for nicotine dependence in the 'hard to treat' tobacco user... - Cigarette smoking predicts differential benefit from naltrexone for alcohol dependenceLisa M Fucito
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA
Biol Psychiatry 72:832-8. 2012..Nevertheless, there is limited research on cigarette smoking as a potential predictor of differential response to pharmacological treatment of alcoholism...
Research Grants
- Naltrexone for Heavy Drinking in Young AdultsSTEPHANIE O MALLEY; Fiscal Year: 2009....
- Trajectories of Drinking and Compliance in the COMBINE StudySTEPHANIE S contact O apos MALLEY; Fiscal Year: 2010..The results of these analyses may offer new theoretical and clinical insights into the use of medications and behavioral interventions for the treatment of alcohol addiction. ..
- Ethanol metabolites for monitoring drinking in clinical trials.STEPHANIE S contact O apos MALLEY; Fiscal Year: 2010....
- Trajectories of Drinking and Compliance in the COMBINE StudySTEPHANIE O MALLEY; Fiscal Year: 2009..The results of these analyses may offer new theoretical and clinical insights into the use of medications and behavioral interventions for the treatment of alcohol addiction. ..
- NALTREXONE & SSRI THERAPY FOR ALCOHOL DEPENDENCESTEPHANIE O MALLEY; Fiscal Year: 2004..abstract_text> ..
- Naltrexone for Heavy Drinking in Young AdultsSTEPHANIE S O apos MALLEY; Fiscal Year: 2010....